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Centenary Meeting, Department ofEpidemiology and
Public Health, The Queen's University ofBelfast,
26-28 September 1996
The Department celebrated its centenary in the
Autumn of last year when a scientific meeting
and social programme took place to mark the
event. The Department was setup in the Autumn
of 1896 when apart-time lectureship in Sanitary
Science was established and held Jointly by a
ProfessorLetts who was achemist and DrHenry
Whitaker, the second Medical Superintendent
OfficerofHealthforBelfast. Subsequently, there
was afull-time lectureship inHygieneandalsoin
Sanitary Science before the Department was
renamed Public Health in 1921. The Chair in
PublicHealthwasheldbyJamesWilsonwhohad
qualified with First Class Honours at Queen's in
1905. TheDepartmentoccupiedtwolaboratories
and some offices on thefirstand second floors of
the old Anatomy building on the main QUB site;
the building sadly was demolished in 1969.
ProfessorWilson made anotable contribution to
research on infectious diseases. He was also
Bacteriologist to the Belfast Water
Commissioners.
Subsequently theDepartmentwasentitledSocial
andPreventiveMedicine, andmovedtotheRoyal
Victoria Hospital in 1954. Professor Alan
Stevenson held the Chair from 1948-1958 when
he became Director ofthe MRC Population and
Genetics Unit in Oxford: he died in 1995.
Professor John Pemberton took over from Alan
Stevenson in 1958 and developed the
Department's interest in cardiovascular
epidemiology. An early prospective study ofthe
developmentofcoronaryheartdiseaseinGeneral
Practice was successfully mounted. In 1965-66 a
study of fatal myocardial infarction in Belfast
paved the way for the introduction of Mobile
Coronary Care by Frank Pantridge. During
Professor Pemberton's time, other departments
grewoutofthegeneraldisciplineofPublicHealth
atQueen's: Medical Statistics, Medical Genetics
and General Practice. He retired in 1976 at the
same time as Professor Peter Froggatt, who had
held a personal chair in the Department, became
Vice-Chancellor. The Department of Social and
Preventive Medicine changed its name to
Community Medicine in 1976 and became the
Department of Epidemiology and Public Health
in 1989.
The present Head ofDepartment is Alun Evans,
Professor of Epidemiology who is involved in a
number of international studies and is currently
the Chairman of the WHO MONICA Project
SteeringCommitteeandCo-ordinatorofthefinal
analyses of the Project through a major grant
from the European Commission. He is also
involved in cardiovascular genetic epidemio-
logical studies with France through the ECTIM
andPRIMEstudies. Thesestudieshaveidentified
major susceptibility genes for cardiovascular
diseases. DrFrankKee,HonorarySeniorLecturer
in Public Health Medicine, is involved in these
genetic studies and Dr John Yarnell is Senior
Lecturer in Cardiovascular Epidemiology with a
special interest in haemostatic factors and
cardiovascular disease. Dr Anna Gavin runs the
recently established Northern Ireland Cancer
Registry and Dr Paul Darragh has an interest in
accident epidemiology; they are both senior
lecturers in Public Health Medicine. The
Biostatistical wing oftheDepartmentis strong in
modelling and survivorship analysis through Dr
Gilbert MacKenzie and MrDerrickBennett; and
Dr Chris Patterson has a special interest in the
epidemiology of diabetes. The Department is in
transition again: it became the Division of
Epidemiology on 1st October 1996.
ALUN EVANS
CURRENT WORK OF THE DEPARTMENT
Kee F, Patterson C C
Dept of Epidemiology and Public Health, Queen's
University Belfast, Northern Ireland, UK.
Muchofthe currentworkoftheDepartmentnow
involves internationalcollaboration, the subjects
encompassing biostatistics, cardiovascular and
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cancer epidemiology, studies of accident
prevention andhealthpromotion, health services
research in cardiology and the genetic
epidemiologyofcardiovascularriskanddiabetes.
* The ECTIM project, a collaboration between
four WHO MONICA centres (Belfast, Lille,
StrasbourgandToulouse)andINSERM(Paris),
firstreported an association in 1992 between a
deletion polymorphism of the angiotensin
converting enzyme gene and myocardial
infarction (MI) risk. The role of a common
polymorphism of the angiotensin II receptor
gene in modifying this risk has now also been
studied. DNAfrom613 cases and723 controls
was assessed to determine the presence of an
A -p C transversion at position 1166 of the
AGT1R gene. The odds ratio forMI associated
with the ACE DD genotype was 1.05 for
subjects without the AGT1R C allele, 1.52 in
ACheterozygotes and 3.95 (1.26 -12.4) in CC
homozygotes (test for trend p<0.02). Fifteen
per cent of individuals carry both the DD
genotype and at least one C allele and thus
these results could have clinical implications
for the prevention and treatment of coronary
heart disease. The ECTIM study extension to
womeninBelfasthasjustfinishedrecruitment:
the study is being repeated in Glasgow.
* UsingdatafromtheNorthernIrelandcolorectal
cancer register for 1990/91, we have assessed
the association between colorectal cancer and
levels of community deprivation. Electoral
wards were grouped into quintiles of the
population after ranking of their Townsend
individual deprivation "scores". Incidence
ranged from 22.5 (for quintile 1) to 29.9/
100,000 (quintile 5) for men but the trend for
females was less regular: 18.4, 23.8, 27.3,
26.5, and 23.9/100,000 for quintiles 1- 5
respectively (iefromthe most"affluent" tothe
most"deprived" fifthsofthepopulation). After
adjustingforageandsexinPoissonregression,
there was a significant association between
total colorectal cancer incidence and levels of
community deprivation, the rate ratio for the
most deprived quintile of the population
(compared to the least) being 1.28 (95% CI.
1.06 -1.53). As others have shown that such
associations asthesearenotexplicableentirely
on the basis of the distribution of known risk
factors, furtherresearch isneededtodetermine
plausible mechanisms for the association.
* Previous attempts to assess what determines
urgencyforbypass surgeryhavenotaccounted
for clinicians' opinions about the efficacy of
surgery for particular types of patients. We
have investigated these using clinical
judgement analysis. Fifty "paper patients"
were assessed by 33 clinicians to determine
their urgency and priority for surgery. A
Clinical Judgement Analysis employed linear
regression models to reflect the impact of
clinical and non-clinical "cues", such as
smoking habitandangina severity, onurgency
and priority decisions. Overall, the decision
modelshadhighexplanatorypower,accounting
for, on average, 73% and 82% of variance of
urgency and priority decisions respectively.
The relative impact of the demographic cues
on urgency and priority was substantially less
than that ofthe clinical cues. The influence of
factors such as smoking habit or body weight
was generally independent of the doctors'
beliefs about the efficacy of the operation. In
lightofthis thebasis oftherhetoric onthepros
and cons of according priority to particular
types ofpatients needs to be re-examined.
* Althoughchildhoodinsulin-dependentdiabetes
mellitus (IDDM) is known to have a strong
genetic component, environmental factors are
also implicated. So far such environmental
risk factors as have been identified are weak.
The available immunological evidence points
to the existence of a long pre-diabetic phase
whenthedestructionofinsulin-producingcells
ofthepancreashasbegun,butthediseaseisnot
yet clinically apparent. This has led to an
increased interest in potential risk factors
operating in the perinatal period and in early
infancy. The Northern Ireland Children's
Diabetes Study is a case control investigation
ofenvironmental risk factors focusing on this
early period. Northern Ireland is one of nine
European centres collaborating in this project
which will provide data on 1,000 cases and
2,000 controls. Data handling and analysis of
the Project is based in Belfast.
THE BRADFORD HILL LEGACY
G MacKenzie
Dept ofEpidemiology and Public Health, Queen's
University Belfast, Northern Ireland, UK.
Sir Austin Bradford Hill's criteria for causality
are re-visited in the context of assessing the
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effects of potential risk factors for CHD in
longitudinal epidemiological studies.
The problem of quantifying the independent
effects of competing risk factors in multifactor
regression analysis is addressed briefly and
reliance on pure significance testing is criticised.
Theneedtoconsidermore substantive modelling
issues is illustrated by analysing further data
from the prospective '1202 middle-aged men'
study ofCHD incidence conducted in Belfast by
Greig etal (1980). Multi-factor analyses at 5 and
7 years of follow-up confirm the findings of the
PoolingProject(1979) inrelationtotheweakness
of the association between CHD incidence and
the three major factors: cholesterol, cigarette
smoking and hypertension. These results lead to
theconclusionthatsuchdataarevirtuallyuseless
for the prediction of the disease status of
individuals on study.
Curiously,thefactthatitwaspossibletodelineate
relative risk successfully seemed to satisfy most
epidemiologists working in this area at thattime.
There was an apparent reluctance to accept that
someimportantriskfactorsmayhavebeenmissed
andthis failure led to adecade (the 70's) ofdelay
inalternativehypothesiselaboration, formulation
andtesting. Italsoledtoover-optimism aboutthe
likely beneficial effects of population-based
multi-factor primary intervention studies which
were conducted up to the mideighties. Since that
time a number of additional hypotheses have
emerged - on fibrinogen, anti-oxidants, and
genetics - andthechallenge forepidemiologists,
today, is to learn how to assess the influence of
these risk factors more efficiently than hitherto.
We argue forcloserinternational co-operation in
the organisation of international prospective
studies, for better hypothesis elaboration -
especiallyinrelationtoclarifyingthemultivariate
dependencies between competing risk factors
(e.g., do current genetic hypotheses purport to
explain existing relationships or are they more
ambitious?), for greater attention to success in
predicting absolute risk, for less weight to
statistical significance in single samples and for
a standard paradigm in which results can be
validated.
Reference:
GreigMary, PembertonJohn, HayIris, andMacKenzie
Gilbert. A prospective study of the development of
coronary heartdisease in agroup ofmiddle-aged men.
J Epid Comm. Hith. 1980; 34, No.1: 23-30.
CORONARY HEART DISEASE AND CORONARY
RISK FACTORS: ARE MEN AND WOMEN
REALLY DIFFERENT?
Hugh Tunstall-Pedoe
Cardiovascular Epidemiology Unit, Ninewells Hospital,
Dundee, Scotland, UK.
There is a shortage of data on coronary disease
and risk factors in women, particularly from
studies whichincludedboth sexes usingthe same
definitions andcriteria. Lackingthesameamount
of data from the two sexes, commentators seem
to have been almost equally biased between
assuming that men and women were the same,
and assuming that they must be different.
Two studies incorporated into the long-term
programme ofthe Cardiovascular Epidemiology
UnitinDundeearehelpingtoanswerthisquestion.
Registration of coronary events in Glasgow for
theWHOMONICAProject(asalsoisbeingdone
in Belfast) produced 3991 events in men overthe
first seven years 1985-91 and 1551 in women
between ages 25 and 64. If the results are
standardized forage side by side comparison can
be made of the circumstances, management and
outcomeinthetwosexes.Foraverylargenumber
ofcomparisonstheresultsareremarkablysimilar,
but there are also differences which the large
numbers are big enough to reveal, which are
subtle but of profound significance. Women
victims are more socially isolated and socially
deprived, are more often affected when at home,
tend to call the GP rather than an ambulance and
take slightly longertoreach hospital, where their
presentation is more complicated than for men,
although investigation and management are very
similar. It has long puzzled investigators that
more womendiedafterarrival inhospital than do
men and the Glasgow MONICA data confirm
this,butthey also show somethingpreviously not
realized, and now confirmed across the
international MONICA Project, that more men
die suddenly outside hospital. In our data the
differences are equal and opposite so that the
proportionbelow age 65 deadby 28 days is equal
at50%,butmenandwomengettherebydifferent
routes.
Our risk factor data are based on the Scottish
Heart Health Study which surveyed 11,600 men
and women between 1984 and 1987 and for
which we have an average of7.6 years offollow-
up data, allowing us to compare the performance
of 26 factors in men and women, as well as the
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menopause in women, in predicting coronary
risk.Wehaveusedriskratios,dividingcontinuous
data into fifths, but also looking at categorical
data according to its classes and have produced a
league table foreach sex showing therankings of
risk ratios in descending order. Again there are
remarkable similarities but subtle differences,
but in this case numbers of end-points are not
largeenoughformanyofthedifferencestoexceed
the play ofchance. However, it is clear that risk
ratios for many factors are higher than in men,
although absolute risk is-lower. Lipid factor
ranking is different in men and women, and most
surprising is what happens to the Bortner score
for"TypeAPersonality"whichisofnopredictive
value in men inthis study, butturns outinwomen
tobeparadoxically andperversely asignificantly
protective factor. Further follow-up data will
helpustodefinethesedifferences moreprecisely.
HAEMOSTATIC AND RHEOLOGICAL FACTORS
AND RISK OF IHD AND STROKE
Gordon D 0 Lowe,1 John W G Yarnell2
1 Department of Medicine, University of Glasgow.
2- Department of Epidemiology and Public Health,
Queen's University of Belfast.
Rheological variables, which increase blood
viscosity and may promote IHD and ischaemic
stroke, include haematocrit, plasma viscosity
(influenced by fibrinogen and lipoproteins) and
white cell count.
In the MRC Epidemiology Unit in South Wales
two prospective studies ofIHD were established
in parallel in the late 1970s. The first study was
based in Speedwell, Bristol and was focused
particularlyonHDLcholesterol(theHDLfraction
had been rediscovered as a risk factor in 1975).
The Caerphilly Study (Caerphilly, South Wales)
was alsobasedon apopulation sample ofmiddle-
aged men and was testing several additional
hypotheses to those being tested in Speedwell.
One strength ofthese studies is the common core
protocol andthemeasurementofseveralputative
risk factors by the same laboratories. This was
true for the haemostatic risk factors measured in
the first phase of both studies. A fibrinogen
measurement using heat precipitation, plasma
viscosity and white blood cell count were
measured in one laboratory, and the Clauss
coagulation fibrinogen, the thrombin time and
the heparin-thrombin clotting time in another.
The results at 5 and at 10 years of follow-up
confirmed the importance ofboth fibrinogen and
white blood cell count as independent predictors
of risk of subsequent IHD. However plasma
viscosity was correlated with fibrinogen
(particularly with that measured by heat
precipitation), andwhetherfibrinogenorviscosity
(or both) is the truly independent risk factor
remains to be resolved. Differential white cell
count was measured in the second phase of the
Caerphillystudyandsignificantassociations were
found between incident IHD and neutrophil and
eosinophil counts.
ResultsfromtheSouthWalesprospective studies
havebeenconfirmedbyScottishstudiesincluding
Scottish Heart Health, Glasgow MONICA,
Edinburgh Artery and WOSCOPS. Viscosity
reductioncanbeachievedbyriskfactorreduction
(smoking, lipoproteins, fibrinogen). The recent
association offibrinogen genotypes with arterial
disease suggests that some fibrinogen elevation
may precede the disease, rather than result from
the disease or from stimulants of arterial
inflammation.
Other haemostatic risk factors investigated for
their association with IHD include; factor VII,
factor VII/von Willebrand factor, plasminogen
activator inhibitor (PAI), tissue plasminogen
activator (tPA) antigen, and fibrin D-dimer.
Results from Caerphilly and elsewhere will be
briefly reviewed, and a case for selective
antithrombotic prophylaxis presented.
RENOVASCULAR DISEASE
A P Maxwell
Regional Nephrology Unit, Belfast City Hospital,
Belfast, Northern Ireland, UK.
Controversy exists regarding the relative
importance of genetic versus environmental
factorsinbloodpressurevariation. Kidneydisease
is the commonest identified cause of secondary
hypertension. Elevated blood pressure is a major
determinant of progressive renal injury leading
toend-stagerenal failure (ESRF), irrespective of
the initial etiology of the renal disease.
Hypertension istwiceascommoninpersonswith
one or two hypertensive parents and genetic
factors may account for 30% of the variation in
blood pressure in various populations. Multiple
crosstransplantation studies in experimental
models of genetic hypertension have indicated
that the kidney is the organ conferring
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predisposition to hypertension. There is clinical
evidencefromhumanrenaltransplantation that a
similarrelationshipmayexist.PatientswithESRF
who receive a kidney transplant from a donor
with hypertensive parents tend to have higher
blood pressures than those receiving atransplant
from donors with normotensive parents.
There are relatively few specific examples of
human genetic mutations which confer a state of
renal hypertension. The commonest monogenic
defect associated with hypertension is adult
polycystic kidney disease. Liddle's syndrome, a
raremonogenichypertensivedisorder, illustrates
the physiological consequences of unregulated
andpersistent distal renal tubule sodium channel
activity. The polygenic contribution to human
hypertensionhasprovedmoredifficulttounravel.
DNA polymorphisms within genes encoding
components of the renin-angiotensin system
(RAS) have been associated with predisposition
to renal disease. Equally intriguing are reports
linking specific RAS gene variants with more
rapid decline in glomerular filtration rate and
resistance to the beneficial effects of ACE
inhibitor therapy. More effective targeting of
clinicalstrategiestoretardprogressiverenalinjury
remains a longer term goal of such population-
based studies involving candidate genes.
A fetal environment which results in low birth
weight has been postulated as a determinant of
blood pressure in adult life. The theory that
maternal malnutrition causes fetal growth
retardation and subsequent adult hypertension is
supported by data describing hypertension in the
offspring of female rats fed low protein diets
during pregnancy. An hypothesis exists that
intrauterinegrowthretardationresultsinimpaired
renal development; this has been termed
"congenital oligonephropathy". A decreased
number of nephrons leads to compensatory
nephron hypertrophy with associatedglomerular
capillary hypertension. This is ultimately a
maladaptive response leading to glomerular
sclerosis and the emergence ofhypertension.
Therefore in asubsetofhypertensivepatients the
origins ofraised blood pressure may be traced to
environmentalinsultswhichdecreasedfunctional
renal mass coupled to genetic variation in the
regulation of renovascular responses to injury.
THE GENETIC EPIDEMIOLOGY OF
CARDIOVASCULAR DISEASE
Frangois Cambien
INSERM SC7, 17 rue du Fer a Moulin 75005 Paris,
France
Coronary heart disease (CHD) is amultifactorial
disease with complex physiopathology; its
frequency increases with age, is higher in males
than in females, varies considerably among
populations and is influenced by a large number
ofenvironmental and hereditary factors. A gene
may be involved in the predisposition to CHD if
itexists underfunctionally differentforms which
may affect regulatory or coding regions of the
gene. This may inducevariabilityofmetabolic or
signalling pathways and have beneficial or
detrimental consequences. By contrast with the
rare highly deleterious mutations causing
monogenic diseases, the known variants
predisposing to CHD do not confer a strong
increase of risk but they are quite common and
thus may have an important impact in terms of
populationattributablerisk. Anotherconsequence
of the high frequency of predisposing alleles is
that their simultaneous presence in an individual
is not rare and may lead to a high risk of CHD.
The candidate gene strategy involves the
following steps:
1. select a candidate gene (a gene which codes
for a protein that may be involved in the
disease process),
2. obtain sequences of coding and regulatory
regions,
3. identify polymorphisms of the gene,
4. measure intermediate phenotypes, such as
the plasma or cellular levels of the coded
protein,
5. look for associations of the genetic
polymorphismswithintermediatephenotypes
and disease, evaluate experimentally the
putative functionality of the variants.
Associations between CHD and polymorphisms
of the ApoE, Apo(a), ApoB, MTHFR and ACE
genes have already been demonstrated and a
large number of genes coding for molecules
involvedinthelocalprocessesthatmaycontribute
to the pathogenesis of CHD are currently being
explored.
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The linkage (sib-pairs) and association (case-
control) approaches arecomplementary. Thefirst
offers the most straightforward way to identify
newgenescontributingtorisk,whereasthesecond
is the best way to study candidate genes. In the
near future, gene-gene and gene-environment
interactions will be investigated in large studies
ofseveral thousand patients. Characterization of
genesinvolvedinthechronic andacuteprocesses
of CHD may considerably improve our
understanding of-theetiology andmechanisms of
this disease.
THE ANTIOXIDANT HYPOTHESIS TEN YEARS
ON
K Fred Gey
Dept of Biochemistry & Molecular Biology, University
of Berne, Switzerland.
Since classical risk factors such as smoking,
hypercholesterolaemia andhypertension explain
only part of the risk of coronary heart disease
(CHD), other factors remain to be evaluated.
Fruit andvegetable-rich diets havebeen strongly
linked to a substantially lower risk of CHD (as
well as tocancer) so anexploration ofpotentially
preventive nutrients is timely. In the Optional
Vitamin Study of the WHO/MONICA Project
the plasma levels ofessential antioxidants, such
as vitamins C and E, in the populations of
Europeancountriescontrasting inCHDmortality
and fruit and vegetable consumption, were
investigated. This study showed a strong inverse
correlation between plasma antioxidants and the
age-standardized mortality of CHD. The
Antioxidant Hypothesis [Bibl Nutr Dieta 1986;
37: 53-91] postulated that a suboptimal
antioxidant status is a hitherto underestimated
risk factor for CHD which may be corrected by a
"prudent diet". Subsequently case-control and
prospective studies in various populations have
shown an increased CHD risk with poor
antioxidant status at the individual level. The
data suggest that, for a country with relatively
poor vegetable consumption, e.g. Great Britain,
the risk factors rank as follows: vitamin E >>
vitamin C . B3-carotene. In some data total
cholesterol and diastolic blood pressure have
beenrankedbelowvitaminE. Allcomplementary
data suggest "optimal" plasma levels to be
approximately .50 tmol/l vitamin C, .30 lImol/
1lipid-standardized vitaminB (alpha-tocopherol/
cholesterol ratio .5.2), and .0.4 pmol/l 13-(.O.5
Ilmol/l total) carotene. Relative risks are doubled
at 25-50% lower levels of each antioxidant, and
multiplicativelyincreasedincombination.Within
the last ten years the antioxidant hypothesis has
gained additional support from data based on the
evaluationofself-prescribedvitaminsupplements
in the USA and randomized double-blind
intervention studies [J Nutr Biochem 1995; 6:
206-236]. A recent British study suggests a
potential for secondary prevention in CHD
patients by large doses of vitamin E.
In conclusion, the best chance to minimize the
risk ofthe multifactorial CHD may be avoidance
of classical risk factors and a concurrent
improvement in micronutrient intake.
HOMOCYSTEINAEMIA
Ian M Graham
Adelaide & Meath Hospitals, Trinity College, Dublin.
Royal College of Surgeons in Ireland.
Homocysteine is a sulphur amino acid produced
by the demethylation ofthe essential amino acid
methionine. Itcandamagevascularendothelium,
affect both platelet function and coagulation
factors, and may promote the oxidation of low
density lipoprotein cholesterol.
Homocystinuria was first described in Northern
Ireland in 1962 by Carson and Neill. It occurs
whenplasmahomocysteinelevelsaresufficiently
highforthedisulphidehomocystinetobeexcreted
in the urine, and is associated with precocious
vascular disease. It is caused most frequently by
the inherited deficiency of the enzyme
cystathionine B-synthase and also by rarer
enzymaticdefects. Recently, acommonmutation
presentinperhapssevenpercentofthepopulation,
thermolabile methyl tetrahydrofolate reductase,
has been associated with less severe
hyperhomocysteinaemia.
Mild elevations ofplasmahomocysteine are also
now known to be unequivocally associated with
increasedriskofatherosclerotic vasculardisease
ofthe coronary, cerebral and peripheral arteries.
The European Concerted Action Project Case
Control Study of750 vascular disease cases and
800 control subjects indicates that afasting level
of plasma homocysteine above 12 umol/L (the
top one fifth ofthe control distribution) doubles
the risk of myocardial infarction, stroke or
peripheral vasculardisease. Over40 case control
and prospective studies confirm this relationship
and indicate a strong, graded and independent
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effect.Furthermore, araisedplasmahomocysteine
level interacts with smoking, hypercholesterol-
aemia and hypertension to further increase risk.
Plasma homocysteine levels are controlled both
byenzymes such as cystathionine B synthase and
by the intake of folic acid, Vitamin B12 and
Vitamin B6, all of which modulate the enzymes
controlling homocysteine levels. Homocysteine
levels increase even at low "normal" levels of
folate intake, and folic acid has a profound
homocysteine loweringeffectinmost subjects. It
may also counteract the effect of thermolabile
methyl tetrahydrofolate reductase. A high fat,
low folate diet, frequent in these islands, may be
particularly atherogenic. Whether or not folate
supplementation may reduce vascular disease
risk is now acritical question, andone which will
be addressed by randomized control trials in the
near future. Only when such trials are complete
will it be possible to determine with certainty
whether the strong relationship between plasma
homocysteine levels and vascular disease is one
of cause and effect.
TEN YEARS AFTER CHERNOBYL, ADJUSTED
MORBIDITY RATES AMONG EMERGENCY
WORKERS
W Morgenstern and V K Ivanov
Dept Clinical Social Medicine, University Hospital
Heidelberg, Heidelberg, Germany and
Medical Radiological Research Centre, Russian
Academy of Medical Sciences, Obninsk, Russia.
The Chernobyl accident - being the largest
radiation disaster in the nuclear industry - has
changed radiation in large geographical areas.
Even ten years afterthe accidentthe impactofits
effects on the health status of the population is
difficult to assess quantitatively and objectively
in scientific terms. For scientific, logistic and
political reasons, sufficientdataare notavailable
and available data are oflimited validity. On the
otherhand, there is adefinite needforoptimising
decisions and measures in order to minimise the
health-damaging consequences of conceivable
future accidents.
Here, theGerman-Russiancollaborativeresearch
projectEffectsofRadioactiveRadiationonHealth
- Risk and Projection Models tries to make a
contribution. It aims at the provision of
methodologies for estimations and projections
that are optimal for the data available as well as
for present scientific knowledge. Bases for this
are mathematical models which differ from
traditional statistics by assessing uncertainties in
data and knowledge explicitly.
A first model of this kind has been designed for
morbidity estimation based on the available data
ofthe Russian National Medical and Dosimetric
Registry. It tries to assess uncertainties in the
dataduetonon-regularparticipationintheannual
follow-up health examinations. In other terms:
unobserved states in the process of disease
registration are modelled to allow morbidity
estimates that are stable with regard to random
fluctuations in the empirical data. A first
application of the model deals with morbidity
dynamics for the period of 1986-1994 among
emergency workers (clean-up workers) at the
nuclear power plant. The results show for 12
major classes of disease groups that incidence
rates (adjusted for this type of uncertainty) are
lower than those observed in the registry. This
differenceisexplainedbyaccumulatedmorbidity
effects duetomissing observations inthe follow-
up examinations.
In addition the results confirm a striking fact.
Among emergency workers - at least in the first
years after the accident - the major concerns in
primaryhealthcarewerepsychosomatic diseases
where a direct dose-effect relation ofradiation is
notknown. Atpresentitisunclearwhetherfurther
modelling will reveal results for a better
understanding of such effects of a nuclear
accident.
However, the model generally deals with the
well-known problem of 'missing follow-up' in
registry systems. Thereby, the application ofthe
modelmaybecomeofgeneralinterest. Webelieve
that traditional statistical methodologies do not
assess the full potential of information in such
registry systems. This may be true at least with
regard to health policy decision making. Here,
problems and objectives are differently defined
as in epidemiological research.
NEW DIRECTIONS FOR EPIDEMIOLOGY?
Russell V Luepker
Division of Epidemiology, School of Public Health,
University of Minnesota.
Epidemiology is in its golden age. The borders of
our research are expanding and are well-
supported. Student applications for training
programs are increasing and our students easily
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findemploymentatuniversities, governmentand
industry. The work that we do is increasingly
appreciated by our colleagues, government and
industry. The public seeks our pronouncements
to make important decisions about their daily
lives.
Yetall is notwell. Recenteditorials such as those
in the Lancet "Do epidemiologists cause
epidemics?" andinScience"Epidemiologyfaces
its limits" question our methods, interpretations
and even importance. In the United States, a
"public interestgroup" supportedbyindustryhas
been established to confront scientific studies
which are deemed "harmful".
Epidemiologists have responded to these
criticisms with disbeliefsuggesting that we only
present the information and others are over-
interpreting. Others blame the press for mis-
reporting and sensationalizing scientific
information. Onfurtherthought, someexperts do
wonder if epidemiologists occasionally over-
interpret associations andrisks. Butwe also need
to do some self-analysis to understand these
criticisms.
Dramatic advances in data collection, data
handling and analyses have occurred. Those who
analyse the data are frequently not those who
collected the information. Powerful software
reducesthetimetoperformananalysistoseconds
wheredayswereformerlynecessary. Allpotential
associations can be analysed and significant,
though marginal, associations will be found. Our
training programs have taught this technology to
our students who have the sophistication of the
latestbiostatisticalmethods.Theyareincreasingly
detachedfromanunderstandingoftheintricacies
of data collection or the pathophysiology of the
diseases that they study. It should not surprise us
if interpretations are flawed.
Finally, while many blame the press for
sensationalizingepidemiologic data, manyofour
colleagues actively seek press exposure. Either
drawn by the bright light of public interest or a
desire to impress political and funding agencies,
they become entangled with the reporters'
objectives to find stories which generate public
interest.
This crisis inetiologic epidemiology is areal and
serious one. It calls for more thoughtful and
conservative interpretation ofdata, bettertraining
of young epidemiologists in the breadth of the
field and more thoughtful relationships with the
media. However, it is also true that etiolgical
epidemiology may actually be reaching its limits
and, while valuable, it is not the direction for
future development of the field.
There are two other important areas of public
healthinquiry suitabletoepidemiologic methods.
The first is in disease surveillance. Measuring
trends over time with careful methods has only
recently become alegitimate andgrowing areaof
research. The importance of understanding not
only the current status of the population health,
but the directions that it is taking are ofimmense
importance and benefit. This applies both to the
general population, the traditional domain of
epidemiology, but also to those who are ill: ie
outcomes and health services research. Here,
epidemiologic rigor and methodology have been
lackingbutareneededfortheimportantdecisions
on allocation and deployment of medical
resources.
The second important area is a reminder of our
history. As the legend tells, John Snow not only
documented and mapped the London Cholera
Epidemic, healsoremovedtheBroadStreetpump
handle, eliminating the source of the infection.
Epidemiology, as the basic science of public
health, must look beyond counting events and
finding associations. Itmustbeready andwilling
along with other public health disciplines to
suggestthealternatives anddirections forsolving
revealed public health problems. Only with this
approach will Epidemiology attain its mission to
improve the public health.
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